News

Dr. Rod J. Rohrich: Celebrated Plastic Surgeon in Dallas

Dr. Rod J. Rohrich: Celebrated Plastic Surgeon in Dallas

Renowned Plastic Surgeon Achieves D Magazine Recognition

Dr. Rod J. Rohrich, a prominent Dallas plastic surgeon, has gained significant recognition by being named one of the best plastic surgeons in Dallas according to a highly respected annual peer-reviewed list by D Magazine. This honor reflects his commitment to excellence and patient care in the field of aesthetic surgery.

A Peer-Reviewed Process Ensuring Top Talent

The selection for the D Magazine's Best Doctors list is a robust process where local physicians nominate specialists they trust to treat their own families. Following this, a rigorous review by a panel of physician advisors takes place, solidifying the trustworthiness of this list. This meticulous process guarantees that patients seeking excellent specialists have a reliable guide in navigating the numerous options available.

Dr. Rohrich's Commitment to Excellence

Dr. Rohrich is a board-certified plastic surgeon with an outstanding reputation for his expertise in rhinoplasty, revision rhinoplasty, and facelift surgery. His clinical practice is centered at the Dallas Plastic Surgery Institute, where he not only performs surgeries but also teaches as a Clinical Professor of Plastic Surgery at Baylor College of Medicine.

His dedication to innovation and patient safety is reflected in his global lectures, where he shares insights on contemporary practices in aesthetic surgery. “It is an honor to be recognized by my peers for excellence in plastic surgery,” states Dr. Rohrich. He believes that such recognitions are instrumental in guiding patients toward informed decisions when selecting a surgeon.

Advancing the Field of Plastic Surgery

Dr. Rohrich’s influence extends beyond his surgical practice. He is well-known for his leadership in plastic surgery, significantly contributing to the advancement of the discipline. His emphasis on evidence-based techniques ensures that each patient receives tailored, ethical care. This commitment to patient education and safety amplifies his reputation internationally.

Acknowledged Contributions and Leadership

Recognized nationally, Dr. Rohrich’s contributions to plastic surgery continue to earn accolades. He chairs significant conferences such as the Dallas Rhinoplasty Meeting and is a founding partner of the Dallas Plastic Surgery Institute. His efforts in education extend to numerous published works, including over 1,000 peer-reviewed articles and eight textbooks, contributing to the body of knowledge in plastic surgery.

Dr. Rohrich’s achievements include being named as one of Newsweek’s top U.S. plastic surgeons in both rhinoplasty and facelift surgery for five consecutive years. He has garnered multiple awards for his dedication to research and education, paving the way for emerging surgeons to follow in his footsteps.

About Dr. Rod J. Rohrich

Based in Dallas, Dr. Rod J. Rohrich is a board-certified plastic surgeon renowned for his expertise. He is affiliated with Baylor College of Medicine and has previously held roles such as the Distinguished Teaching Professor and Chair at UT Southwestern Medical Center. His extensive training includes institutions like Baylor, University of Michigan, Harvard/Mass General, and Oxford.

Dr. Rohrich's leadership in the field and active participation in medical societies have positioned him at the forefront of plastic surgery, making significant strides toward enhancing both practice and patient outcomes. His dedication to the field is evident, with ongoing contributions to surgical education and patient care.

Contact Information

For inquiries, Dr. Rod J. Rohrich can be contacted at the following details:

Rod J. Rohrich, MD, FACS
Dallas Plastic Surgery Institute
9101 N Central Expy #600, Dallas, TX 75231
Office: (214) 821-9114

Frequently Asked Questions

What makes Dr. Rod J. Rohrich a leading plastic surgeon?

Dr. Rohrich has been recognized for his expertise in procedures like rhinoplasty and facelift surgery and has received numerous awards for his contributions to the field.

How is the D Magazine Best Doctors list compiled?

It is created through a peer-nomination process where local physicians nominate doctors they trust, followed by verification by a panel of advisors.

What is Dr. Rohrich's teaching role?

Dr. Rohrich is a Clinical Professor of Plastic Surgery at Baylor College of Medicine, where he educates future surgeons on various techniques.

Why is patient safety emphasized in Dr. Rohrich's practice?

Patient safety is paramount to achieving the best surgical results, and Dr. Rohrich focuses on evidence-based techniques in all his procedures.

Where can I find more information about Dr. Rohrich's services?

More details about Dr. Rohrich’s practice can be found through direct contact or by visiting his professional website.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 146

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Fibocom Unveils U6G Solutions Advancing Global 5G Tech

Updated Category News Views 60

Breaking Barriers with U6G-Capable Technology Sneaking into the industry's spotlight at MWC Doha 2026, Fibocom flaunts a robust lineup of next-gen 5G solutions. It's as if they're shuffling every card they’ve got to win over the broadband world. With breakthroughs like the FG390, FG370, and FG670 modules, alongside PCBA-level innovations, Fibocom is not just throwing...

Continue Reading
Strathcona and Greenfire Set Sights on Major Merger

Updated Category News Views 68

Strathcona's Bold Move for Greenfire: A Game Changer? Just this week, Strathcona Resources Ltd. decided to make a big splash in the oil sands space by proposing to acquire Greenfire Resources Ltd. This isn’t your run-of-the-mill grab—it's a strategic tango expected to shift billions and reshape what we know about Canada’s oil sands territory. Unpicking the Deal...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 272

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 354

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 414

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 646

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Cars.com Inducement Awards: New CPO Earns Stock Boost

Updated Category News Views 22

Revving Up With Incentives: A Strategic Move by Cars.com Ever seen a stock maneuver that feels more like a chess play than a plain deal? On November 5, 2026, Cars.com (NYSE: CARS) fired up quite a strategic engine. They handed out a heap of restricted stock units—373,345 to be precise—to Mausam Bhatt, freshly minted as their Chief Product Officer. This isn't just your...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 586

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading

Top 5 Most Recently Viewed Articles

Spring Health Launches Initiative for Mental Health Relief

Updated Category News Views 472

Spring Health's Commitment to Mental Health Support In response to the recent devastation from the wildfires, Spring Health has announced a significant initiative aimed at providing mental health resources to those in distress. The company has committed $500,000 to launch a new Wildfire Mental Health Support Program aimed at individuals and families impacted by these...

Continue Reading
Serina Therapeutics Showcases Innovations at Global Conference

Updated Category News Views 263

Serina Therapeutics Takes the Stage at Major Investment Event Serina Therapeutics, Inc., also known as Serina (NYSE American: SER), is set to make an impactful presentation at the H.C. Wainwright 27th Annual Global Investment Conference. This prestigious event unfolds in New York City, where Steve Ledger, the Chief Executive Officer of Serina, will take the spotlight at...

Continue Reading
Patrick Industries Faces Scrutiny Amid Merger Plans

Updated Category News Views 48

Cracks in the Merger Deal? Nobody likes it when a seemingly routine merger suddenly faces the magnifying glass of a class action attorney. But that's where we are with Patrick Industries (NASDAQ: PATK), folks. Juan Monteverde, the big hitter from Monteverde & Associates, is eyeing this one closely. This New York-based firm, perched in the legendary Empire State Building...

Continue Reading
Revolutionary Arab Human Pangenome: Advancing Genomic Equity

Updated Category News Views 124

Groundbreaking Achievement in Genomics PacBio, a renowned leader in sequencing technology, has made a substantial contribution to global genomics with the announcement of the first Arab human pangenome. This historic achievement is powered by their innovative HiFi long-read sequencing technology, showcasing the potential of genomic science to progress health equality...

Continue Reading
RCI Hospitality Secures Significant Legal Representation Ahead of Deadline

Updated Category News Views 226

Introduction to RCI Hospitality Holdings, Inc. RCI Hospitality Holdings, Inc. (NASDAQ: RICK) is known for its diverse portfolio in the hospitality sector. With establishments across the country, RCI focuses on providing entertainment and dining experiences through various brands. As an investor in RCI Hospitality, it’s essential to stay informed about recent legal...

Continue Reading